Search Orphan Drug Designations and Approvals
-
Generic Name: | Ancrod |
---|---|
Date Designated: | 10/20/1989 |
Orphan Designation: | To establish and maintain anticoagulation in heparin-intolerant patients undergoing cardiopulmonary bypass. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Knoll Pharmaceutical Company 3000 Continental Dr., North Mt. Olive, New Jersey 07828 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-